论文部分内容阅读
目的 :评价含异长春花硷 (NVB)的联合化疗方案治疗晚期非小细胞肺癌 (NSCLC)的疗效及不良反应。方法 :对 2 6例晚期NSCLC患者采用含NVB联合方案化疗 ,均经细胞学或病理证实。结果 :完全缓解 1例 ,部分缓解 10例 ,有效率42 3%。其中NP方案治疗 16例 ,有效率 37 5 % ,NIP方案治疗 16例 ,有效率 5 0 % ,两方案无显著性差异。中位缓解期 6个月 ,中位生存期 9 5个月。主要不良反应为骨髓抑制、恶心呕吐、脱发、便秘、静脉炎。结论 :含NVB的联合化疗方案对晚期NSCLC有明显疗效 ,主要的不良反应是骨髓抑制和静脉炎。
Objective: To evaluate the efficacy and adverse reactions of combination chemotherapy with NVB in the treatment of advanced non-small cell lung cancer (NSCLC). Methods : Twenty-six patients with advanced NSCLC were treated with NVB combined regimen. All of them were confirmed by cytology or pathology. Results: There was complete remission in 1 case, partial remission in 10 cases, and an effective rate of 42 3%. Among them, 16 cases were treated with NP regimen, the effective rate was 37.5%, 16 cases were treated with NIP regimen, and the effective rate was 50%. There was no significant difference between the two regimens. The median remission period is 6 months, and the median survival period is 9 months. The main adverse reactions were myelosuppression, nausea, vomiting, hair loss, constipation, and phlebitis. Conclusion : The combined chemotherapy regimen with NVB has obvious curative effect on advanced NSCLC. The main adverse reactions are myelosuppression and phlebitis.